SCHEMBL13945566

SCHEMBL13945566

CCOC(=O)Cn1c(=O)n(Cc2cc(OC)c3ccccc3n2)c(=O)c2c1nc(N1CCCC(N)C1)n2CC

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 19/20 0.49
▸ CHRM1 P11229 2/20 0.48
▸ POU2F2 P09086 1/20 0.48
▸ ADORA3 P0DMS8 1/20 0.48
▸ POU2F1 P14859 1/20 0.48
▸ CHRM3 P20309 1/20 0.48
▸ HRH2 P25021 1/20 0.48
▸ MC4R P32245 1/20 0.48
▸ FAP Q12884 1/20 0.48
▸ DPP8 Q6V1X1 1/20 0.48
▸ DPP9 Q86TI2 1/20 0.48
▸ GHSR Q92847 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13944305 0.95 DPP4 (0.50) DPP4CHRM1POU2F2ADORA3POU2F1
SCHEMBL8270387 0.92 DPP4 (0.60) DPP4CHRM1POU2F2ADORA3POU2F1
SCHEMBL13945308 0.87 DPP4 (0.64) DPP4CHRM1POU2F2ADORA3POU2F1
SCHEMBL8270386 0.86 DPP4 (0.62) DPP4CHRM1POU2F2ADORA3POU2F1
SCHEMBL8270420 0.86 DPP4 (0.57) DPP4CHRM1POU2F2ADORA3POU2F1
SCHEMBL8269355 0.84 DPP4 (0.49) DPP4CHRM1POU2F2ADORA3POU2F1
SCHEMBL8270404 0.83 DPP4 (0.49) DPP4CHRM1POU2F2ADORA3POU2F1
SCHEMBL8271383 0.83 DPP4 (0.64) DPP4CHRM1POU2F2ADORA3POU2F1
SCHEMBL13944846 0.83 DPP4 (0.60) DPP4CHRM1POU2F2ADORA3POU2F1
SCHEMBL13946074 0.82 DPP4 (0.62) DPP4CHRM1POU2F2ADORA3POU2F1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7495003-B2 8-(3-amino-piperidin-1-yl)-7-(but-2-ynyl)-xanthines, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-02-24 — — US disclosed
Send feedback